Predictive oncology sends letter to shareholders regarding special meeting to be reconvened on december 30, 2020

New york, dec. 09, 2020 (globe newswire) -- predictive oncology (nasdaq: poai), a knowledge-driven company focused on applying artificial intelligence (“ai”) to personalized medicine and drug discovery, today sent a letter to shareholders regarding its virtual special meeting of stockholders, original scheduled for december 1, 2020, which will be reconvened december 30, 2020 at 3 p.m. cst.
POAI Ratings Summary
POAI Quant Ranking